UY35918A - Formas cristalinas de un compuesto antiviral - Google Patents
Formas cristalinas de un compuesto antiviralInfo
- Publication number
- UY35918A UY35918A UY0001035918A UY35918A UY35918A UY 35918 A UY35918 A UY 35918A UY 0001035918 A UY0001035918 A UY 0001035918A UY 35918 A UY35918 A UY 35918A UY 35918 A UY35918 A UY 35918A
- Authority
- UY
- Uruguay
- Prior art keywords
- crystal forms
- antiviral compound
- compound
- forms
- dioxadiazacycloneonedecino
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000013078 crystal Substances 0.000 title abstract 2
- 230000000840 anti-viral effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 125000006432 1-methyl cyclopropyl group Chemical group [H]C([H])([H])C1(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 abstract 1
- APSYYKGWNWKKOC-UHFFFAOYSA-N quinoxaline-5-carboxamide Chemical compound C1=CN=C2C(C(=O)N)=CC=CC2=N1 APSYYKGWNWKKOC-UHFFFAOYSA-N 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361920427P | 2013-12-23 | 2013-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY35918A true UY35918A (es) | 2015-05-29 |
Family
ID=52282995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001035918A UY35918A (es) | 2013-12-23 | 2014-12-23 | Formas cristalinas de un compuesto antiviral |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9562058B2 (enExample) |
| EP (1) | EP3087086B1 (enExample) |
| JP (2) | JP6568541B2 (enExample) |
| AR (1) | AR098958A1 (enExample) |
| AU (1) | AU2014370124A1 (enExample) |
| CA (1) | CA2934049A1 (enExample) |
| ES (1) | ES2708993T3 (enExample) |
| NZ (1) | NZ720887A (enExample) |
| PT (1) | PT3087086T (enExample) |
| TW (1) | TW201609752A (enExample) |
| UY (1) | UY35918A (enExample) |
| WO (1) | WO2015100144A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2934537C (en) * | 2013-12-23 | 2022-08-16 | Gilead Sciences, Inc. | Synthesis of an antiviral compound |
| WO2016106050A1 (en) | 2014-12-26 | 2016-06-30 | Emory University | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
| JOP20170127A1 (ar) * | 2016-06-02 | 2017-12-02 | Gilead Pharmasset Llc | صيغة مشتركة مكونة من ثلاث مركبات مضادة للفيروسات |
| RU2020116571A (ru) | 2017-12-07 | 2021-11-22 | Эмори Юниверсити | N4-гидроксицитидин и производные и связанные с этим противовирусные применения |
| CN115417803B (zh) * | 2022-08-30 | 2023-10-03 | 四川同晟生物医药有限公司 | 乌帕替尼中间体(3r,4s)-1-苄氧羰基-4-乙基吡咯烷-3-羧酸的合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| CL2008003384A1 (es) * | 2007-11-14 | 2009-12-11 | Enanta Pharm Inc | Compuestos derivados de quinoxalina macrocíclica, inhibidores de serina proteasa; composicion farmaceutica que los comprende; y su uso en el tratamiento de la hepatitis c. |
| ES2392611T3 (es) * | 2008-07-22 | 2012-12-12 | Merck Sharp & Dohme Corp. | Compuestos de quinoxalina macrocíclica como inhibidores de la proteasa NS3 del VHC |
| TWI523658B (zh) * | 2010-09-21 | 2016-03-01 | 安塔製藥公司 | 巨環脯胺酸衍生之ｈｃｖ絲胺酸蛋白酶抑制劑 |
| WO2012040040A1 (en) * | 2010-09-21 | 2012-03-29 | Merck Sharp & Dohme Corp. | Hcv ns3 protease inhibitors |
| US20130164260A1 (en) | 2011-11-16 | 2013-06-27 | Gilead Sciences, Inc. | Antiviral compounds |
| UA119315C2 (uk) | 2012-07-03 | 2019-06-10 | Гіліад Фармассет Елелсі | Інгібітори вірусу гепатиту с |
-
2014
- 2014-12-18 CA CA2934049A patent/CA2934049A1/en not_active Abandoned
- 2014-12-18 NZ NZ720887A patent/NZ720887A/en not_active IP Right Cessation
- 2014-12-18 PT PT14824322T patent/PT3087086T/pt unknown
- 2014-12-18 WO PCT/US2014/071310 patent/WO2015100144A1/en not_active Ceased
- 2014-12-18 US US14/575,966 patent/US9562058B2/en active Active
- 2014-12-18 EP EP14824322.3A patent/EP3087086B1/en active Active
- 2014-12-18 AU AU2014370124A patent/AU2014370124A1/en not_active Abandoned
- 2014-12-18 JP JP2016560857A patent/JP6568541B2/ja not_active Expired - Fee Related
- 2014-12-18 ES ES14824322T patent/ES2708993T3/es active Active
- 2014-12-22 TW TW103144805A patent/TW201609752A/zh unknown
- 2014-12-23 AR ARP140104909A patent/AR098958A1/es unknown
- 2014-12-23 UY UY0001035918A patent/UY35918A/es not_active Application Discontinuation
-
2016
- 2016-12-21 US US15/387,318 patent/US9862728B2/en active Active
-
2019
- 2019-02-07 JP JP2019020540A patent/JP2019089819A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US9562058B2 (en) | 2017-02-07 |
| JP2017503016A (ja) | 2017-01-26 |
| AR098958A1 (es) | 2016-06-22 |
| EP3087086A1 (en) | 2016-11-02 |
| US20170267694A1 (en) | 2017-09-21 |
| US9862728B2 (en) | 2018-01-09 |
| US20150175625A1 (en) | 2015-06-25 |
| NZ720887A (en) | 2018-01-26 |
| PT3087086T (pt) | 2019-02-06 |
| EP3087086B1 (en) | 2018-11-07 |
| JP6568541B2 (ja) | 2019-08-28 |
| CA2934049A1 (en) | 2015-07-02 |
| ES2708993T3 (es) | 2019-04-12 |
| AU2014370124A1 (en) | 2016-06-23 |
| TW201609752A (zh) | 2016-03-16 |
| JP2019089819A (ja) | 2019-06-13 |
| WO2015100144A1 (en) | 2015-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT201700136A (es) | Formas sólidas de un inhibidor ask 1 | |
| DK3699181T3 (da) | Krystallinsk form af (s)-n-(5-((r)-2-(2,5-difluorphenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidin-1-carboxamidhydrogensulfat | |
| EA201690617A1 (ru) | Комбинирование anti-lag-3-антител и анти-pd-1-антител для лечения опухолей | |
| CL2018001722A1 (es) | Nuevos anticuerpos anti-mfi2 y métodos de uso (divisional solicitud 201700506) | |
| TWD169700S (zh) | 針盤 | |
| EP3254654A4 (en) | Stretch structure for absorbent article, and underpants-type disposable diaper using same | |
| TWD170353S (zh) | 項鍊 | |
| EA201691473A1 (ru) | Биспецифические анти-il-13/il-17 антитела и их применение | |
| TWD166825S (zh) | 飾品 | |
| EP3037852A4 (en) | Wafer lens, wafer lens array, wafer lens laminate, and wafer lens array laminate | |
| EP3326413A4 (en) | USER LEVELS FOR CELLULAR ARCHITECTURE OF THE FIFTH GENERATION | |
| EA201690513A1 (ru) | Комбинация ингибитора mek и ингибитора erk для применения в лечении гиперпролиферативных заболеваний | |
| DOP2017000288A (es) | Moduladores alostéricos positivos del receptor muscarínico m2. | |
| AR098958A1 (es) | Formas cristalinas de un compuesto antiviral antecedentes | |
| WO2015058132A3 (en) | Anti-rsp02 and/or anti-rsp03 antibodies and their uses | |
| WO2014153495A3 (en) | Novel stat3 inhibitors | |
| EP3279254A4 (en) | Polypropylene for film condenser, biaxial stretching film for film condenser, film condenser and manufacturing methods therefor | |
| BR112015026827A2 (pt) | Formas polimórficas de cloridrato de nilotinibe | |
| MX2018005987A (es) | Compuestos heterociclicos para el tratamiento de enfermedades. | |
| WO2014146111A3 (en) | Analgesic compounds and methods of use | |
| EP3067969A4 (en) | Negative electrode material for secondary battery, and secondary battery using same | |
| EP3236520A4 (en) | Negative-electrode active material for electrical device, and electrical device using same | |
| EP3067970A4 (en) | Negative electrode material for secondary battery, and secondary battery using same | |
| EP3376570A4 (en) | Negative-electrode active material for electrical device, and electrical device in which said material is used | |
| AR100289A1 (es) | Formas de un inhibidor de pi3k |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20211230 |